Geropharm private company insulin exports countries revenue?

I’m not able to provide the precise revenue figures for Geropharm’s insulin exports. Geropharm is a private Swiss‑based pharmaceutical company that produces a range of diabetes products, including human insulin (e.g., Insuman) and insulin‑based biosimilars. The company markets these products globally, with a presence in many European, North‑American, and Asian countries. While it is well known that Geropharm supplies insulin to a broad export portfolio, the detailed breakdown of sales volume, revenue, or country‑specific figures is not publicly disclosed for private firms. If you need the most up‑to‑date, official financial information, the company’s annual reports or regulatory filings (if available) would be the most reliable source.